 |
A newsletter for those involved in clinical trials. Published 20 times a
year by Canary LtdOrphan drugs
The following articles on this topic have been published in
CRAdvisor (CRA) – the year, issue number
and starting page number for each are listed below:
Back to index |
| 2007 |
|
|
CRA 2007; 193:6 |
EMEA guideline on trials in small populations. |
| |
|
| 2006 |
|
| CRA 2006; 164:1 |
All-time high for number of orphan drug designations. |
|
CRA 2006; 168:3 |
European experience with orphan drug development. |
| |
|
| 2004 |
|
| CRA 2004; 140:6 |
Update to guide for orphan products. |
| CRA 2004; 141:1 |
EU regulation proposed for promoting medicines for
children. |
| |
|
| 2002 |
|
| CRA 2002; 99:8 |
New regulatory documents. |
| CRA 2002; 101:6 |
Design of orphan drugs trials in children. |
| |
|
| 2001 |
|
| CRA 2001; 66:2 |
National measures for orphan drug research. |
| CRA 2001; 67:6 |
EMEA orphan fee reductions. |
| |
|
| 2000 |
|
| CRA 2000; 43:6 |
Regulation on orphan medical products enters into force. |
| CRA 2000; 48:6 |
Orphan medicinal products. |
| CRA 2000; 56:6 |
EMEA has many orphans. |
| |
|
| 1999 |
|
| CRA 1999; 33:6 |
Orphan drug regulations. |
| CRA 1999; 39:4 |
Orphan drug regulations - timetable of events. |